Search clinical trials for: US-licensed Humira

Total 1075 results

Ain Shams University

Completed

Cavitation Ultrasound in Treatment of Patients With PCOS

PCOS

Egypt
Arcturus Therapeutics, Inc.
Novotech (Australia) Pty Limited; Seqirus

Recruiting

Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults

Influenza, Human

Australia
Thomas Jefferson University

Recruiting

Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

Breast Carcinoma

United States
Philipp Fürnstahl
KU Leuven; Swiss Center for Musculoskeletal Imaging

Completed

Robot-Assisted US-Based Vertebral Segmentation for Pedicle Screw Trajectory Identification

Healthy

Switzerland
Wake Forest University Health Sciences

Withdrawn

Hidradenitis Suppurativa Patient Experience With Humira Treatment

Hidradenitis Suppurativa

United States
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa (PIONEER II)

Hidradenitis Suppurativa (HS)
AbbVie

Completed

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis (UC)

United States, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Netherlands, Poland, Romania, Slovakia, Spain, Switzerland, Ukraine, United Kingdom
Boehringer Ingelheim

Completed

BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

Crohn Disease

Serbia, United Kingdom, United States, Czechia, Germany, Greece, Poland, Russian Federation, Turkey, Israel, Belarus, Ukraine, Croatia, Bosnia and Herzegovina
Boehringer Ingelheim

Completed

Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis

United States, Germany, Russian Federation, Czechia, Poland, Ukraine, Estonia, Slovakia
AbbVie

Completed

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Crohn's Disease
AbbVie (prior sponsor, Abbott)

Completed

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

Rheumatoid Arthritis

Australia, Canada, Germany
AbbVie (prior sponsor, Abbott)

Completed

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

Mexico
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa (PIONEER I)

Hidradenitis Suppurativa (HS)
AbbVie

Completed

Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China

Rheumatoid Arthritis
AbbVie

Completed

Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

Generalized Pustular Psoriasis (GPP) | Adalimumab | Japanese
Abbott

Completed

Long Term Open Label Continuation Study

Rheumatoid Arthritis

United States, Canada
Abbott

Completed

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis (ReAlise)

Rheumatoid Arthritis

Australia, Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Portugal, Spain, United Kingdom
Abbott

Completed

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

Crohn's Disease

United States, Australia, Belgium, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, South Africa, Spain, Sweden, United Kingdom
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

Influenza

United States, Finland, Philippines, Thailand
Indiana University

Completed

Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure. (VATS)

Pain, Postoperative | Pain, Acute | Video Assisted Thoracoscopic Surgery

United States
Fowler Kennedy Sport Medicine Clinic
Zimmer Biomet

Completed

Cemented vs. Non-Cemented TSA for OA of the Shoulder

Osteoarthritis

Canada
Lawson Health Research Institute

Terminated

Improving Mobility and Cognition in Older Adults Using Non-Invasive Brain Stimulation (NIBS)

Executive Dysfunction | Repetitive Transcranial Magnetic Stimulation | Gait Performance

Canada
AbbVie

Completed

A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan

Pyoderma Gangrenosum

Japan
Coherus Biosciences, Inc.

Completed

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis (PsOsim)

Plaque Psoriasis

United States, Canada, Bulgaria, Chile, Croatia, Estonia, Georgia, Israel, Italy, Latvia, Moldova, Republic of, Poland, Russian Federation, Slovakia, South Africa, Ukraine
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Moderate to Severe Rheumatoid Arthritis (Auriel-RA)

Moderate to Severe Rheumatoid Arthritis

Bulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
AbbVie
Raffeiner GmbH

Completed

Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice (Adherence)

Rheumatoid Arthritis | Plaque Psoriasis | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis | Crohn´s Disease
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

Crohn's Disease
AbbVie

Completed

A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease

Crohn's Disease
AbbVie (prior sponsor, Abbott)
Eisai Co., Ltd.

Completed

A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease

Intestinal Behçet's Disease

Japan
AbbVie (prior sponsor, Abbott)

Completed

Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.

Rheumatoid Arthritis

Belgium, Czech Republic
University of Wisconsin, Madison

Recruiting

An Imaging-based Quantitative Biomarker Assay for NAFLD in Children

NAFLD | NASH

United States
Eslam Ayman Mohamed Shawki

Completed

Predicting Resting Energy Expenditure in Critically Ill Patients by Measuring Lean Body Mass by US

Resting Energy Expenditure

Egypt
Biocon Biologics Inc.
MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. Ltd

Completed

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Moderate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis

Bulgaria, Czechia, Estonia, Poland
Wayne State University
Abbott

Terminated

Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis

Psoriasis
The First Affiliated Hospital of the Fourth Military...

Active, not recruiting

Remote Breast Cancer Screening Study

Breast Cancer | Ultrasound Imaging | Mass Screening | Cancer Screening | AI (Artificial Intelligence)

China
Ain Shams University

Completed

Role of Lung Ultrasound In Assessment Of Recruitment Maneuvers In Ventilated Preterms With Respiratory Distress Syndrome and Its Correlation With Tracheal IL-6 Level

Respiratory Distress Syndrome, Newborn

Egypt
Heinrich-Heine University, Duesseldorf

Completed

Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy

Prostate Cancer

Germany
Fudan University

Recruiting

Cryoablation Combined With Sintilimab Plus Regorafenib In Previously Treated Colorectal Cancer Liver Metastasis

Colorectal Cancer Metastatic | Liver Metastases

China
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Ultrasound-assisted vs Landmark Based Intrathecal Administration of Nusinersen

Muscular Atrophy, Spinal | Ultrasound

Italy
Pfizer

Completed

A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia

Aplastic Anemia

Japan
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institute of Dental and Craniofacial...

Completed

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

Fibrosis | Lymphedema | Oropharyngeal Cancer | Oral Cavity Cancer

United States
Manuel C. Vallejo

Completed

A Novel Way to Estimate Epidural Depth in Morbidly Obese Parturient

Obesity

United States
Mallinckrodt

Completed

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

Keratitis

United States
Huons Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee

Osteoarthritis of Knee

Korea, Republic of
University of Melbourne

Completed

Influenza Vaccine in HIV Study

Influenza, Human
Alvotech Swiss AG

Completed

PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

Phase 1

New Zealand
AbbVie

Completed

A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis (VISUAL III)

Uveitis
AbbVie (prior sponsor, Abbott)

Completed

Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis

Ulcerative Colitis
AbbVie

Completed

Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients (AS PMOS)

Ankylosing Spondylitis

Search clinical trials for: US-licensed Humira

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations